BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9815805)

  • 1. Antitumor efficacy of N1,N11-diethylnorspermine on a human bladder tumor xenograft in nude athymic mice.
    Sharma A; Glaves D; Porter CW; Raghavan D; Bernacki RJ
    Clin Cancer Res; 1997 Aug; 3(8):1239-44. PubMed ID: 9815805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
    Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
    Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells.
    Kramer DL; Fogel-Petrovic M; Diegelman P; Cooley JM; Bernacki RJ; McManis JS; Bergeron RJ; Porter CW
    Cancer Res; 1997 Dec; 57(24):5521-7. PubMed ID: 9407962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice with activated polyamine catabolism due to overexpression of spermidine/spermine N1-acetyltransferase show enhanced sensitivity to the polyamine analog, N1, N11-diethylnorspermine.
    Alhonen L; Pietilä M; Halmekytö M; Kramer DL; Jänne J; Porter CW
    Mol Pharmacol; 1999 Apr; 55(4):693-8. PubMed ID: 10101027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of spermidine/spermine N1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N1, N11-diethylnorspermine.
    Gabrielson E; Tully E; Hacker A; Pegg AE; Davidson NE; Casero RA
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):122-6. PubMed ID: 15138709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
    Porter CW; Bernacki RJ; Miller J; Bergeron RJ
    Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts.
    Bernacki RJ; Bergeron RJ; Porter CW
    Cancer Res; 1992 May; 52(9):2424-30. PubMed ID: 1568212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of polyamine catabolism by N1,N11-diethylnorspermine leads to cell death in glioblastoma.
    Jiang R; Choi W; Khan A; Hess K; Gerner EW; Casero RA; Yung WK; Hamilton SR; Zhang W
    Int J Oncol; 2007 Aug; 31(2):431-40. PubMed ID: 17611701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal sequestration of polyamine analogues in Chinese hamster ovary cells resistant to the S-adenosylmethionine decarboxylase inhibitor, CGP-48664.
    Kramer DL; Black JD; Mett H; Bergeron RJ; Porter CW
    Cancer Res; 1998 Sep; 58(17):3883-90. PubMed ID: 9731498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
    Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
    Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer.
    Wolff AC; Armstrong DK; Fetting JH; Carducci MK; Riley CD; Bender JF; Casero RA; Davidson NE
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5922-8. PubMed ID: 14676116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
    Bergeron RJ; Weimar WR; Luchetta G; Streiff RR; Wiegand J; Perrin J; Schreier KM; Porter C; Yao GW; Dimova H
    Drug Metab Dispos; 1995 Oct; 23(10):1117-25. PubMed ID: 8654201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polyamine analogue N1,N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines.
    Stanic' I; Facchini A; Borzì RM; Stefanelli C; Flamigni F
    J Cell Physiol; 2009 Apr; 219(1):109-16. PubMed ID: 19097065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying N1, N11-diethylnorspermine-induced apoptosis in a human breast cancer cell line.
    Holst CM; Staaf J; Jönsson G; Hegardt C; Oredsson SM
    Anticancer Drugs; 2008 Oct; 19(9):871-83. PubMed ID: 18766001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diethyl spermine analogues in human bladder cancer cell lines in culture.
    Chang BK; Liang Y; Miller DW; Bergeron RJ; Porter CW; Wang G
    J Urol; 1993 Oct; 150(4):1293-7. PubMed ID: 8371417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination effects of platinum drugs and N1, N11 diethylnorspermine on spermidine/spermine N1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants.
    Tummala R; Diegelman P; Hector S; Kramer DL; Clark K; Zagst P; Fetterly G; Porter CW; Pendyala L
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):401-14. PubMed ID: 20443003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the methylene backbone in the antiproliferative activity of polyamine analogues on L1210 cells.
    Bergeron RJ; Hawthorne TR; Vinson JR; Beck DE; Ingeno MJ
    Cancer Res; 1989 Jun; 49(11):2959-64. PubMed ID: 2720656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
    Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A
    Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.